⌘K

Login Start Free

Home/Filings/4/0000899866-19-000077

4//SEC Filing

ORLOFF JOHN J 4

Accession 0000899866-19-000077

CIK 0000899866other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 6:39 PM ET

Size

4.8 KB

Accession

0000899866-19-000077

Insider Transaction Report

Form 4

Period: 2019-06-07

ALEXION PHARMACEUTICALS, INC.ALXN

EVP, Research & Development

Transactions

Tax Payment
Common Stock, par value $.0001 per share
2019-06-07$118.61/sh−2,786$330,447→ 37,791 total

Footnotes (1)

[F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.

Documents

1 file

4
wf-form4_156029278196014.xmlPrimary
FORM 4

Issuer

ALEXION PHARMACEUTICALS, INC.

CIK 0000899866

Entity typeother

Related Parties

1

filerCIK 0001643941

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 6:39 PM ET
Size: 4.8 KB

View on SEC.gov